» NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015

CAMBRIDGE, Mass., March 20, 2015 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., today announced that Jonathan Solomon, CEO, will participate on an expert panel, "Neuroscience Therapeutics Development: Challenges, Opportunities and the Road Ahead," at the Massachusetts...

» Computational tool identifies 800 risk factors for PTSD
Researchers have developed a computational tool that can establish the risk of post-traumatic stress disorder developing in individuals within ten days of a traumatic event.

» Colorado's Legal Pot Is Potent, and a Little Dirty
Title: Colorado's Legal Pot Is Potent, and a Little Dirty
Category: Health News
Created: 3/23/2015 12:00:00 AM
Last Editorial Review: 3/23/2015 12:00:00 AM